Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0007097 (carcinoma)
 152,788 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

There is a need to establish the diagnosis of cancer of the larynx as early as possible. Delay in making the diagnosis should occur rarely if all of the available methods are fully utilized. Having established the presence of a carcinoma it should be possible to define the site and extent of the tumor; only with this additional information can the best treatment be selected. The use of a fiber-optic laryngoscope or a telescopic laryngoscope (Gould) has made examination of the "difficult larynx" more satisfactory. X-ray examination, with or without contrast material, has provided useful information regarding extent of the tumor, particularly with regard to its relation to the glottis. Microscopic laryngoscopy has proven to be a most reliable way to identifying "the early lesion" and of establishing the extent of an established tumor, especially if supravital staining is applied and the microsurgical laryngeal mirror and laryngeal caliper are used. The most difficult diagnosis to make at the present time is the presence of residual tumor after radiation, when the tumor does not present on the surface. The solution to this problem will not be found easily.
 ...
PMID:Diagnosis of carcinoma of the larynx: a review of current methods. 4 97

Morphologic, tissue culture, immunologic, and biochemical methods have been used in an attempt to detect and characterize oncogenic viruses or their subviral components in cells derived from human prostatic carcinoma (PrCa) or benign prostatic hyperplasia (BPH). Electron microscopy was used to characterize the ultrastructural features of normal and neoplastic prostatic tissue. Examination of specimens of prostatic tissue from 34 patients with PrCa, ten patients with BPH, and three patients with bladder tumor (BT) revealed the presence of particles resembling type-C virus in three cases of PrCa and structures resembling budding type-C virus particles in one case of BPH. Fifty human prostatic tissue specimens have been set in tissue culture, of which 30 have been successfully grown for varying periods of time. Of 20 currently active cultures, nine consist primarily of epithelial cells. Immunofluorescence and mixed hemadsorption tests of cells derived from benign and malignant prostatic tissue and sera derived from patients with PrCa, BPH, BT, and other types of tumors, and from normal donors revealed that sera from patients with PrCa, BPH, or BT contain antibodies to antigens in cells derived from PrCa, BPH, or BT. The nature of these antigen-antibody reactions is under study. Initial biochemical studies have not detected reverse transcriptase in the tissue culture fluid from a small number of sparsely growing PrCa cultures nor specific gene sequences homologous to murine leukemia virus-Rauscher genomic RNA in preparations of either normal or malignant prostatic cell DNA. The results of these preliminary studies have demonstrated the applicability of the techniques employed to the study of the relationship of viruses to human PrCa and have provided a number of promising leads for further investigation.
Cancer Chemother Rep
PMID:Virologic and immunologic studies of human prostatic carcinoma. 4 14

SV-40-transformed hamster prostatic tissue has been previously evaluated as a model for human prostatic carcinoma. Because the original cell line was lost, Syrian golden hamster prostatic tissue has been established in explant culture and infected with a 10-6-cell tissue culture infectious dose (50 percent effective) of SV40. After in vitro transformation, the cells were produced in quantity and 60 times 10-6 cells were injected into adult male Syrian golden hamsters 24 hours after 400 rads of whole-body radiation. After 60-90 days, a small palpable tumor developed. These tumors could be serially transplanted in adult male animals without immunosuppression. The tumor cells were established in tissue culture and the cells were returned to adult animals without immunosuppression where they rapidly produced fast-growing tumors. The solid tumors were composed of sheets of pleomorphic polygonal cells with large nuclei and many nucleoli; they resembled undifferentiated human prostatic carcinoma. In vitro, the cultures contained small, rapidly growing cells with a population doubling time of about 1.3 days. The cells carried the SV 40-specific antigen. The modal chromosome number was 66-68 with a distribution of 47-120. Cells exposed to 2-bromo-5'-deoxyuridine in culture did not release particles with RNA-dependent DNA polymerase activity. Endocrine sensitivity in vivo and in vitro is undertermined to date.
Cancer Chemother Rep
PMID:Properties of prostatic cultures transformed by SV40. 4 16

The objective of this study was to isolate, characterize, and preserve normal prostatic epithelial and carcinoma cell lines. To date, four specimens have been acquired from patients with benign prostatic hypertrophy. Culture attempts have been successful, yielding a total of 32 cell lines. Three of these lines have been examined thus far and were found to have clearly demonstrable tartrate-inhibitable acid phosphatase granules by histochemical techniques. Several problem areas emerge from these preliminary studies. These involve the difficulty of (a) characterization of the cells as originating from prostatic epithelium, (b) identification of prostatic carcinoma cells, and (c) possible senescence in culture of cell lines.
Cancer Chemother Rep
PMID:Monolayer cultures of human prostatic cells. 4 17

"Hyaline inclusions" of a meningothelial meningioma were examined under the electron microscope. These eosinophilic, PAS-positive proteinaceous structures, which under the light microscope are seen in both extra- and intracellular location, were found by electron microscopy to consist of granular masses surrounded by cell membranes with microvilli. The "intracellular" bodies were also surrounded by similar microvilli in a space within the cells. Such spaces, variously known as intracellular ductules and "neolumen formation", have been previously described in mammary cancer, bronchiolar carcinoma and pleural mesotheliomas, among others, and have been, in the latter instances, regarded as signs of secretory differentiation. Thus, hyaline inclusions of meningiomas are different from truly intracellular hyaline bodies of neoplastic astrocytes (found by Rubinstein and Herman to be bodies within autophagic vacuoles) and may be regarded as a possible factor in ultrastructural differential diagnosis between meningiomas and gliomas.
 ...
PMID:The fine structure of hyaline inclusions (pseudopsammoma bodies) in meningiomas. 4 2

In vitro, colony inhibition tests using lymphocytes and serum from 42 patients with other carcinomas, and 12 control patients with no carcinoma, were performed using cultured target cells (CALI). Target cell colony counts were significantly diminished by lymphocytes of 2 of 12 (16.7 percent) patients with no cancer, compared with those 26 of 42 (61.9 percent) patients with epidermoid carcinoma. An unexpected finding was significant colony inhibition of lymphocytes of 23 of 27 (85.2 percent) patients tested within 24 months of diagnosis of carcinoma compared with significant inhibition in only 3 of 15 (20 percent) patients tested after 24 months of diagnosis of carcinoma. Serum blocking factor was found in 9 of 42 (21.4 percent) patients with epidermoid carcinoma. It was found on follow-up that four of these nine (44.4 percent) had later recurrent or new tumors compared to recurrence or new tumor incidence of only 6 of 33 (18.2 percent) patients with no serum blocking factor present in the serum.
 ...
PMID:A search for common tumor specific antigen and serum blocking factor in head and neck epidermoid carcinomas. 4 34

As a pre- or postoperative measure, radiotherapy can contribute to the treatment of many gastrointestinal malignancies. Postoperative radiotherapy is recommended in malignant lymphoma of the stomach and the intestine, as well as for invasive and totally resected carcinoma of the recto-sigmoid in order to prevent local recurrences. Preoperative radiotherapy can be attempted for carcinoma of the lower third of the esophagus and extended carcinoma of the stomach and the rectum, as long as no better therapeutic association is available. Finally, curative radiotherapy can be administered for squamous cell carcinoma of the esophagus and the anus, with a reasonable chance of success, to avoid subjecting the patient to major surgery.
 ...
PMID:[Indications for radiotherapy in gastrointestinal tumors]. 4 22

TA3Ha/MSWBS hybrid cells have been derived from the fusion of the TA3Ha ascites carcinoma (H-2a) and the methylcholanthrene-induced MSWBS ascites sarcoma (H-2s). MSWBS expresses a strong tumor-specific transplantation antigen (TSTA), capable of inducing a rejection reaction in the syngeneic A.SW host. The genetic determinants of the H-2 complex are known to be localized on chromosome No. 17. TA3Ha contributes two normal, telocentric chromosomes No. 17 to the hybrid. In contrast, both chromosomes No. 17 of MSWBS are localized on readily identifiable translocations (17/1 and 17/M1 ; see Wiener et al., 1974). We have previously shown that the chromosomes No. 17 of one parental strain, or the other (but not both) can be removed from the hybrid by selective passage in the opposite parental strain. The present paper examined the possibility, often suggested in the literature, that the MC-sarcoma-associated TSTA could be a modified form of H-2. MSWBS, unselected TA3Ha/MSWBS and YACIR/MSWBS hybrids were compared with TA3Ha/MSWBS-derived isoantigen loss variants, with regard to their immunogenicity in the TSTA test, i.e. their ability to induce rejection of MSWBS target cells in ASW mice. Whereas the unselected hybrids were as immunogenic as the parental MSWBS line itself, two strain A compatible and two strain A.SW compatible variants which had lost chromosome No. 17 of the opposite strain showed a residual, but clearly weakened immunogenicity. Since there was no systematic difference between the reciprocal types, it is concluded that the genetic determinant of TSTA is not localized on the chromosome No. 17 but that a proper balance of this chromosome is required for the full expression of immunogenicity in the TSTA system.
Int J Cancer 1975 Jun 15
PMID:Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants? 5 Feb 91

One hundred eighty-nine patients received a four-drug combination consisting of cyclophosphamide, Oncovin (vincristine), methyl CCNU, and bleomycin (COMB), according to three different drug regimens, performed sequentially. Of the 189, 62 had a partial response (33%) including 11/33 with squamous lung cancer, 11/32 with squamous carcinoma of the head and neck, 13/15 with oat cell carcinoma of the lung, and 7/41 with malignant melanoma. The response rate for patients with squamous lung or head and neck cancer appeared to be higher at weekly bleomycin doses of 30 and 60 mg (15/33 = 45%), compared to a weekly bleomycin dose of 15 mg (7/32 = 25%). A median survival from treatment of 30 weeks was observed in oat cell carcinoma, which represents considerable prolongation over that expected from supportive care alone or single-agent chemotherapy. Toxicity included: 1) myelosuppression, resulting in hospitalization for antibiotics in 20% of patients; 2) probable bleomycin lung damage in 4% of patients; and 3) dose-limiting vincristine neuropathy in 11%. The combination of twice-weekly vincristine and bleomycin for more than 6 weeks produced a disturbing "debilitation syndrome," characterized by weakness, anorexia, weight loss, and apathy. The encouraging response rate suggests a future role for these drugs in combination, especially for vincristine and bleomycin, with other agents showing activity in squamous and oat cell carcinoma. Toxicity precludes recommendation of this combination, in the regimens tested, for broader Phase III studies.
Cancer 1975 Aug
PMID:COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors. 5 Aug 70

Alpha1 (alpha 1) fetoprotein (AFP) radioimmunoassay method was routinely used in addition to liver scintigraphy to detect a primary hepatic cell carcinoma, and the diagnostic accuracy of both methods was compared. Twenty-one of 27 cases (78%) with primary hepatic cell carcinoma showed a positive AFP titer of over 200 ng/ml. In 3 of these AFP-positive cases, no focal defects could be found in liver scintigraphy, although subsequently performed celiac angiography revealed hypervascular shadows. On the contrary, 22 of 27 cases (81%) represented well-defined focal defects on scintigraphy. In 4 of these cases with a positive scan, the result of AFP was found to be negative. The overall diagnostic accuracy for detecting primary hepatic cell carcinoma with a combination of both methods was 93%.
Cancer 1975 Aug
PMID:Comparison of alpha1 fetoprotein radioimmunoassay method and liver scanning for detecting primary hepatic cell carcinoma. 5 Aug 72


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>